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Magnesium has been favorable associated with many cardiovascular
(CVD) risk factors. Previous studies on dietary magnesium and risk of CVD
have yielded inconsistent results, possibly due to the use of dietary
questionnaires or blood levels to assess magnesium exposure. Whether
urinary excretion of magnesium, as reﬂection of actual dietary uptake, is
associated with CVD risk remains unclear.
We prospectively followed 7747 adults free of diagnosed cardiovascular
diseases or cancer at baseline (1997-1998) from the community-based,
observational PREVEND (Prevention of Renal and Vascular End-Stage
Disease) Study. Urinary magnesium excretion was estimated from two 24-
h urine collections and was measured by a xylidyl blue method on a
Modular analyzer (Roche). During a median follow-up of 10.5 year, 638
CVD events occurred. After adjustment for age, BMI, sex, smoking status,
alcohol consumption and educational attainment, urinary magnesium
excretion showed a nonlinear relationship with CVD risk. The hazard ratios
(HR) for CVD were signiﬁcantly lower (Po0.05) among the highest four
quintiles compared with the lowest sex-speciﬁc quintile (men: o2.56
mmol/24h; women: o2.09 mmol/24h). The lowest sex-speciﬁc quintile
had an increased risk of CVD (HR, 1.53; 95% conﬁdence interval (CI), 1.26-
1.84) compared with the rest of the cohort after adjustment for
confounders and urinary cations. Further adjustment for C-reactive protein,
systolic blood pressure, total to HDL cholesterol ratio and type 2 diabetes,
did not appreciably alter this association (HR, 1.44; 95% CI, 1.18-1.75).
>In conclusion, low urinary magnesium excretion was associated with a
higher risk of CVD, even after controlling for possible intermediates in the
causal pathway such as blood pressure, diabetes and markers of
inﬂammation and atherosclerosis. These results highlight the need to
evaluate whether increasing the uptake of dietary magnesium could be
effective for primary prevention of CVD.
http://dx.doi.org/10.1016/j.krcp.2012.04.41895
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HbA1c has been widely used as a clinically important assessment tool for
outcome analyses related to glycemic control. However, there is no HbA1c-
blood glucose equation formula speciﬁc for hemodialysis (HD) patients. In
this study, we sought to develop HbA1c-blool glucose equation models fordialysis patients. We examined associations between HbA1c levels and
random serum glucose levels over time in a contemporary cohort of 18,361
diabetic maintenance HD patients treated in DaVita dialysis clinics from
July 2001 through June 2006 with 276,277 paired measurements of HbA1c
and glucose. Time-averaged HbA1c values and blood glucose (BG) values
were compared using regression models with and without adjustment for
hemoglobin, albumin, patients’ age, gender, and/or race/ethnicity to
determine a new equation model. The new models were compared to the
previously reported equations (DCCT and ADAG).modal formula adjust R2Our modal BG¼53.7þ28.8*HbA1c-18.2*Alb 0.3243
DCCT BG¼35.6*HbA1c-77.3 0.3141
ADAG BG¼28.7*HbA1c-46.7 0.3141In conclusion, the association between HbA1c and BG in HD patients is
different from non-HD patient. Our proposed model results in better
estimated BG level in HD patients compared to previously reported models.
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Serum albumin is one of the strongest mortality-predictors in MHD
patients. Yet, the degree to which serum albumin represents dietary
protein intake or inﬂammation is not clear. We hypothesized that
inadequate protein intake and inﬂammation contribute equally to
hypoalbuminemia and examined correlates of low serum albumin o3.8 g/
dL in 812 MHD patients in whom interleukin-6 (IL-6) and normalized
protein nitrogen appearance (nPNA), also known as normalized protein
catabolic rate (nPCR), were also measured. Logistic regression estimated
odds ratios were employed and spline models were plotted to examine the
likelihood of low serum albumin o3.8 g/dL. Mean age (7SD) of patients
was 54715 years; 53% of patients were men, 50% Hispanic, 31% African-
American and 55% diabetic. The unadjusted correlation coefﬁcients of IL-6
and nPNA with serum albumin were -0.36 and þ0.20, respectively
(po0.001 for each comparison). The likelihood for an albumin o3.8 gr/dL
increased linearly with decreasing nPNA and rising serum IL-6. This trend
was steeper with increasing serum IL-6 up to a concentration of 30 ng/ml
(Figure). Hence, both low protein intakes and a high state of inﬂammation
are associated with low serum albumin in MHD patients.
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